Jeffrey M Saland, MD, MSCR
- PROFESSOR | Pediatrics, Nephrology
Specialties:Pediatric Nephrology and Hypertension, Pediatrics
Jeff Saland, MD is the Chief of the Division of Pediatric Nephrology and Hypertension at the Mount Sinai Kravis Children's Hospital and Medical Director of the Pediatric Kidney Transplant Service at the Recanati Miller Transplant Institute (RMTI) of Mount Sinai. Dr. Saland’s clinical practice involves the entire range of diagnosis and treatment of kidney diseases in children including dialysis and kidney transplantation. Examples of conditions treated are nephrotic syndrome, glomerulonephritis, HUS, tubular and acid disorders, kidney stones, vesicoureteral reflux, hydronephrosis, genetic diseases, kidney injury due to toxic medications or injury, as well as kidney disease due to cysts or other malformations. Integrated and consultative care with the pediatric urology service is a hallmark of the practice when the urinary tract is involved. Dr. Saland’s practice also includes prenatal consultation when monitoring suggests a kidney problem during pregnancy. In addition to management of kidney disease, the diagnosis and treatment of high blood pressure in children is another major focus of Dr. Saland’s clinical practice, which includes access to ambulatory blood pressure monitoring. Dr. Saland supervises outpatient office visits, inpatient care, and both home and in-center dialysis, and he is involved in teaching fellows and residents.
- Acute Renal Failure
- Acute Tubular Necrosis
- Congenital Kidney Disease
- Hematuria (Blood In The Urine)
- Kidney Biopsy
- Kidney Stones
- Kidney Transplant
- Nephrotic Syndrome
- Urinary Tract Infection
MD, The University of New Mexico School of Medicine
Residency, Pediatrics, Children's National Medical Center
Fellowship, Nephrology, University of Texas Southwestern Medical School
Fellowship, Pediatric Nephrology, Mount Sinai Hospital
NY Magazine Best Doctors
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Saland during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Alnylam Pharmaceuticals; Miscellaneous MedicoLegal
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.